Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
Similar Posts
Geisinger Partners with Nym Health to Launch Autonomous Coding Technology
CLU technology is a new approach to coding, a step beyond CAC Nym Health, pioneers of Clinical Language Understanding…
MedAware Partners with athenahealth’s Marketplace Program to Provide Clinicians with an Effective Medication Safety Monitoring System
Athenahealth Adds MedAware to Marketplace Program to Address Medication Errors MedAware, a medication safety monitoring technology, announced a partnership…
Customized, Mobile COVID-19 Testing Programs Launch in Massachusetts
Mobile Healthcare Services Brings Experienced Field Providers to Conquer the Last Mile in Healthcare and Make On-the-Go Patient Care…
